C12N 2501/065
Modulators of histone acetylation
C12N2501/065 (Modulators of histone acetylation) appears on 121 US grants and 281 published applications in this corpus.
Search patents in C12N- Granted patents
- 121
- Published applications
- 281
- Assignees
- 167
- Inventors
- 529
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 2 |
| 2009 | 0 | 2 |
| 2010 | 0 | 10 |
| 2011 | 0 | 11 |
| 2012 | 2 | 15 |
| 2013 | 1 | 13 |
| 2014 | 5 | 3 |
| 2015 | 11 | 12 |
| 2016 | 9 | 17 |
| 2017 | 10 | 24 |
| 2018 | 15 | 20 |
| 2019 | 6 | 20 |
| 2020 | 9 | 23 |
| 2021 | 10 | 29 |
| 2022 | 13 | 15 |
| 2023 | 5 | 18 |
| 2024 | 10 | 15 |
| 2025 | 8 | 17 |
| 2026 | 5 | 9 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Immune cells derived from induced pluripotent stem cell14 Jul 2026US 12,680,075 B2Children's Medical Center Corporation
- Methods of enhancing stem cell differentiation into beta cells26 May 2026US 12,637,661 B2Vertex Pharmaceuticals Incorporated
- Compositions and methods for generating physiological X chromosome inactivation26 May 2026US 12,637,697 B2Children's Medical Center Corporation
- Methods for reprogramming cells and uses thereof12 May 2026US 12,624,342 B2Genesis Technologies Limited
- Method to generate induced oligodendrocyte-lineage cells and treatment using such cells17 Feb 2026US 12,553,028 B2Academia Sinica
- Reprogramming method27 Aug 2026US 2026/0250639 A1The Babraham Institute
- Methods of enhancing stem cell differentiation into beta cells20 Aug 2026US 2026/0242740 A1Vertex Pharmaceuticals Incorporated
- Methods of enhancing stem cell differentiation into beta cells13 Aug 2026US 2026/0234563 A1Vertex Pharmaceuticals Incorporated
- Method for reprogramming human somatic cells into induced pluripotent stem cells14 May 2026US 2026/0132384 A1Exoneuglia Biotechnology (Suzhou) Co., Ltd.
- Age-modulating compounds and methods for making age-modulated cells7 May 2026US 2026/0125647 A1Memorial Hospital for Cancer and Allied Diseases
Most cited
By later US patents
- Medium for growing human embryonic stem cells127US 7,297,539 B2Geron Corporation · 2007
- Culture system for rapid expansion of human embryonic stem cells97US 7,410,798 B2Geron Corporation · 2008
- Method for producing virus vector33US 9,102,943 B2Takara Bio Inc. · 2015
- Remnant tumor infiltrating lymphocytes and methods of preparing and using the same27US 11,220,670 B2Iovance Biotherapeutics, Inc. · 2022
- Remnant tumor infiltrating lymphocytes and methods of preparing and using the same27US 11,293,009 B2Iovance Biotherapeutics, Inc. · 2022